Celebrating our Centennial

In 2027, the department will celebrate our centennial year. We take this monumental occasion as an opportunity to reflect on our past 100 years of excellence, dedication, and growth while looking forward to the future; and how our work today will shape the ever-evolving field of radiology.

Honoring the Past: Highlights

1927: UW Board of Regents Appoints Ernst Pohle as UW’s First Professor of Radiology

The German-born Ernst Pohle, MD came to the US in 1923, and after stints at Mt. Sinai in Cleveland and the University of Michigan, took charge of UW’s Department of Radiology. A prototype physician-scientist, Dr. Pohle was primarily interested in the use of radium and x-ray therapy in the treatment of cancer.

1959: John Juhl and Lester Paul Create Groundbreaking Textbook

“The Essentials of Roentgen Interpretation” is published, authored by John H. Juhl, MD and Lester W. Paul, MD. The all-inclusive radiology textbook was quickly established as a unique and first rate compendium of the field.

1981: Digital Subtraction Angiography Unveiled

After nearly a decade of collaboration between Charles Mistretta, PhD and Andrew Crummy, MD, the first commercial prototype of a digital subtraction angiography (DSA) instrument was unveiled at the 1981 Radiological Society of North America (RSNA) meeting. Soon, Mistretta and his departmental colleagues were in extreme demand across the globe to explain and demonstrate the capabilities of DSA.

1996: Mistretta, Grist, and Korosec Develop 3D TRICKS

3D time-resolved imaging of contrast kinetics (TRICKS) is an improved version of time-resolved MR angiography and remains the preferred commercial method to this day. Charles Mistretta, PhD; Thomas Grist, MD and Frank Korosec, PhD, were the inventors of 3D TRICKS. Their work on time-resolved contrast-enhanced 3D MR Angiography was published in Magnetic Resonance in Medicine.

2004: First Human Trial of Innovative Cancer Agent

The first patient was dosed with NM404, a cancer therapy agent developed by Jamey Weichert, PhD. The agent has demonstrated tumor uptake in over 50 types of cancer and can be used for both diagnostic and therapeutic applications.